Drug Database
Back to search

United States· US:51672-4186_535716aa-d92d-98e9-e063-6294a90a7826

Felbamate

A felbamate product containing felbamate, registered in United States by Sun Pharmaceutical Industries, Inc.. The same ATC class is registered in 9 of our 19 countries.

ATC N03AX10

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFelbamateATCN03AX10REGISTER NO.US:51672-4186_535716a…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about felbamateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Felbamate is registered in 9 of 19 countries.

Countries holding a registration under ATC N03AX10 (felbamate), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose
Search felbamate products by name

Felbamate · ATC N03AX10

9 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Italyprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of felbamate costs, country by country.

Normalised to the WHO defined daily dose (2.4 g), the median price runs from $4.40 in United States to $10.58 in Switzerland — a ×2.4 gap.

  • United States: $4.40 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Felbamate · price per daily dose (2.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$10.58
  • IT Italy$9.01
  • US United States$4.40 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
FELBAMATE
Manufacturer
Sun Pharmaceutical Industries, Inc.
Country
United States (US)
ATC code
N03AX10
ATC class
Felbamate
Defined daily dose
2.4 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    51672-4186-1
  • ndc11
    51672-4186-6

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

267 interactions on record for felbamate.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check felbamate against other medicinesHow interaction checks work

Felbamate · interactions on record

267 records

  • 12 severe
  • 221 moderate
  • 7 minor

Most severe, free to view

  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Desogestrel and ethinylestradiolG03AA09severe
  • Drospirenone and ethinylestradiolG03AA12severe
  • EthinylestradiolG03CA01severe

27 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Felbamate in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All felbamate products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Taloxa
  • Belgium · Taloxa-Susp, Taloxa-Tabs
  • Germany · Taloxa, Taloxa Saft
  • France · Taloxa
  • Hungary · Taloxa
  • Italy · Taloxa
  • Luxembourg · Taloxa-Susp, Taloxa-Tabs
  • Netherlands · Taloxa-Susp, Taloxa-Tabs
  • Norway · Taloxa
  • Portugal · Taloxa
  • Sweden · Taloxa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3071b13b-aedd-403b-a957-a3e81f412e5e
GET /v1/drugs/3071b13b-aedd-403b-a957-a3e81f412e5e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "600",
  "substance": "FELBAMATE",
  "productndc": "51672-4186",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA207093",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about felbamate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console